[Hepatoprotective effects of extracts and polysaccharides from seaweed].

Q4 Medicine Antibiotiki i Khimioterapiya Pub Date : 2014-01-01
N N Besednova, T S Zaporozhets, T A Kuznetsova, S P Kryzhanovskiĭ, N N Kovalev, T N Zviagintseva
{"title":"[Hepatoprotective effects of extracts and polysaccharides from seaweed].","authors":"N N Besednova,&nbsp;T S Zaporozhets,&nbsp;T A Kuznetsova,&nbsp;S P Kryzhanovskiĭ,&nbsp;N N Kovalev,&nbsp;T N Zviagintseva","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Antioxidants of natural origin are considered as possible agents for prevention and treatment of liver diseases. Marine algae and in particular their extracts and obtained from them sulfated polysaccharides are significant sources of natural antioxidants. The recent data on the effect of the extracts and sulfated polysaccharides of seaweed on the functional activity of the liver with injuries induced by CCl4, some drugs (paracetamol, diclofenac), N-nitrosocompounds, aflatoxin are presented in the review. Particular attention is paid to the effect of sulfated polysaccharides and in particular fucoidans on the functional activity of the liver in patients with chronic viral hepatitis C. Fucoidan is highly safe and active not only as an antioxidant but also as an inhibitor of HCV replication, has antiinflammatory and immunomodulating effects. The data of the review allow to conclude that seaweed extracts and sulfated polysaccharides may be a basis for development of new generation drugs in the future for the treatment and prevention of liver diseases.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"59 3-4","pages":"30-7"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotiki i Khimioterapiya","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Antioxidants of natural origin are considered as possible agents for prevention and treatment of liver diseases. Marine algae and in particular their extracts and obtained from them sulfated polysaccharides are significant sources of natural antioxidants. The recent data on the effect of the extracts and sulfated polysaccharides of seaweed on the functional activity of the liver with injuries induced by CCl4, some drugs (paracetamol, diclofenac), N-nitrosocompounds, aflatoxin are presented in the review. Particular attention is paid to the effect of sulfated polysaccharides and in particular fucoidans on the functional activity of the liver in patients with chronic viral hepatitis C. Fucoidan is highly safe and active not only as an antioxidant but also as an inhibitor of HCV replication, has antiinflammatory and immunomodulating effects. The data of the review allow to conclude that seaweed extracts and sulfated polysaccharides may be a basis for development of new generation drugs in the future for the treatment and prevention of liver diseases.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[海藻提取物和多糖的肝保护作用]。
天然来源的抗氧化剂被认为是预防和治疗肝脏疾病的可能药物。海洋藻类,特别是其提取物和从中获得的硫酸盐多糖是天然抗氧化剂的重要来源。本文综述了近年来海藻提取物和硫酸酸化多糖对CCl4、部分药物(扑热息痛、双氯芬酸)、n -亚硝基化合物、黄曲霉毒素等损伤后肝脏功能活性的影响。特别关注硫酸酸化多糖,特别是岩藻糖聚糖对慢性病毒性丙型肝炎患者肝脏功能活性的影响。岩藻糖聚糖不仅是一种抗氧化剂,而且是一种HCV复制抑制剂,具有高度安全性和活性,具有抗炎和免疫调节作用。综述的数据表明,海藻提取物和硫酸酸化多糖可能是未来开发治疗和预防肝脏疾病的新一代药物的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Antibiotiki i Khimioterapiya
Antibiotiki i Khimioterapiya Medicine-Infectious Diseases
CiteScore
0.80
自引率
0.00%
发文量
46
期刊最新文献
Modern Ideas about Vaccination of Patients with Rheumatic Diseases: the View of ACR Experts Dynamics of Reserve Antimicrobial Drug Consumption in Russian Hospitals: Impact of the COVID-19 Pandemic Rationality of Cytoflavin Inclusion in the Treatment of Patients with Dermatological Pathology Comorbid with Mental Disorders Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment The Results of Preclinical Studies Assessing the Effect of Riamilovir on the Reproductive Function and Postnatal Growth of Offspring in Laboratory Animals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1